Your browser doesn't support the HTML5 video tag.
Safety and efficacy were a win-win for the MitraClip device in the COAPT trial of moderate-to-severe, symptomatic mitral regurgitation patients with heart failure who had exhausted pharmaceutical options.
CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.